Dr. Erik J. Spek, Ph.D., has been the Head of Intellectual Property at Vedanta Biosciences, Inc. since joining in October 2015. Dr. Spek joins Vedanta Biosciences from Epizyme, Inc., a clinical stage biopharmaceutical company focusing on epigenetic targets, where he served as Director of IP. Prior to Epizyme, he worked at Boston-based IP law firm Wolf Greenfield, focusing on prosecution, FTO, and due diligence in a variety of bio and pharma related technologies. Dr. Spek graduated cum laude from Suffolk Law School, has a B.S. in Chemistry and Philosophy from Vrije Universiteit in Amsterdam, a PhD in Biophysical Chemistry from New York University, and conducted his Postdoctoral Research in Biological Engineering at MIT.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)